Nonsuicidal Self-Injury
Conditions
Keywords
Nonsuicidal Self-Injury (NSSI), Deliberate Self-Harm (DSH), Self-harm, Self-injury
Brief summary
The primary aim is to investigate the effectiveness of an Internet-delivered Emotion Regulation Individual Therapy for Adolescents (ERITA) with nonsuicidal self-injury (NSSI).
Interventions
BEHAVIORALInternet-delivered Emotion Regulation Individual Therapy for Adolescents
Sponsors
Karolinska Institutet
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
A primary diagnosis of NSSI as defined in Section 3 in the fifth edition of the Diagnostic and Statistical Manual 5 of the American Psychiatric Association (DSM-5) \< 1 NSSI episode during the past month At least one parent needs to commit to participate in the parent program
Exclusion criteria
Bipolar disorder I or primary psychosis Severe suicidal ideation Ongoing substance dependence Insertion/withdrawal of psychopharmacological substances within two months prior to the treatment Other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in first hand Current life circumstances that would hinder the treatment (i.e. ongoing domestic abuse) insufficient Swedish language skills Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral therapy (DBT)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Deliberate Self-Harm Inventory - 9 item version | Baseline (30 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks), and three and six months follow-up | Change from baseline in self-harming behaviors when measures weekly, after 12 weeks, and at 3 and 6 months after treatment has ended |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Borderline Symptom List Behavior supplement (BSL-supplement) | Baseline (30 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks), and three and six months follow-up | Change from baseline in self-destructive behaviors when measures weekly, after 12 weeks, and at 3 and 6 months after treatment has ended |
| Difficulties in Emotion Regulation Scale -16 item version (DERS-16) | Baseline (30 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks), and three and six months follow-up | Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks, and at 3 and 6 months after treatment has ended |
| Difficulties in Emotion Regulation Scale (DERS) | Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up] | Change from baseline in difficulties in emotion regulation after 12 weeks, at 3 and 6 months after treatment has ended |
| Borderline personality features in childhood (BPFS-C) | Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up] | Change from baseline in symptoms of borderline personality disorder after 12 weeks, at 3 and 6 months after treatment has ended |
| The Revised Child Anxiety and Depression Scale - Child and Parent rated (RCADS-C) | Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up] | Change from baseline in anxiety and depression after 12 weeks, at 3 and 6 months after treatment has ended |
| Suicidal Ideation Questionnaire (SIQ-JR) | Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up] | Change from baseline in suicidal ideation after 12 weeks, at 3 and 6 months after treatment has ended |
| Acceptance and Action Questionnaire (AAQ-7) | Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up] | Change from baseline in acceptance and action after 12 weeks, at 3 and 6 months after treatment has ended |
Other
| Measure | Time frame | Description |
|---|---|---|
| The treatment credibility scale | One week after treatment start | Perceived treatment credibility |
| Working Alliance Inventory (WAI) short version | Three weeks after treatment start | Perceived working alliance |
| The Client Satisfaction Questionnaire (CSQ) | Twelve weeks after treatment start | Perceived client satisfaction |
| Adverse events | 12 weeks, and at 3 and 6 months after treatment has ended | Adverse events |
| Adult ADHD Self-Report Scales (ASRS) | At baseline | Self-reported symptoms of attention-deficit/hyperactivity disorder (ADHD) |
| Parental Psychological Flexibility (PPF) Questionnaire | Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up] | Change from baseline in parental psychological flexibility after 12 weeks, at 3 and 6 months after treatment has ended |
| The Coping with Children's Negative Emotions Scale Adolescent Version (CCNES-A) | Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up] | Change from baseline in parental coping after 12 weeks, at 3 and 6 months after treatment has ended |
| The Parenting Sense of Competence (PSOC) Scale | Baseline (7 days prior to treatment start), post-treatment (12 weeks), three and six months follow-up] | Change from baseline in parental coping after 12 weeks, at 3 and 6 months after treatment has ended |
Countries
Sweden
Outcome results
None listed